People: Catalyst Pharmaceutical Partners Inc (CPRX.O)

CPRX.O on Consolidated Issue listed on NASDAQ Capital Market

3.06USD
23 Jan 2015
Change (% chg)

$0.19 (+6.62%)
Prev Close
$2.87
Open
$2.94
Day's High
$3.07
Day's Low
$2.90
Volume
1,804,556
Avg. Vol
496,320
52-wk High
$3.49
52-wk Low
$1.70

Search Stocks

O'Keeffe, Charles 

Brief Biography

Mr. Charles B. O'Keeffe is Lead Independent Director of Catalyst Pharmaceutical Partners, Inc. Mr. O’Keeffe also served as a consultant to us from December 2004 until June 2011. Mr. O’Keeffe is a Professor in the Departments of Pharmacology, Epidemiology and Community Health at Virginia Commonwealth University (“VCU”), and has served in such capacity since January 1, 2004. Mr. O’Keeffe joined VCU after retiring as President and Chief Executive Officer of Reckitt Benckiser Pharmaceuticals, Inc., a position Mr. O’Keeffe held from 1991 until 2003. As President of Drug Abuse Rehabilitation Services (from 1970 until 1971), he developed the first child-resistant, abuse-resistant vehicle for dispensing methadone. He served as president of Washington Reference Laboratories from 1972 until 1975, which provided toxicology services to the Department of Defense during the Vietnam War. He has served in the White House (from 1970 until 1973 and from 1976 until 1980) for three presidents—as advisor, special assistant for international health and deputy director for international affairs in the Office of Drug Abuse Policy—and has served on U.S. delegations to the World Health Assembly and the U.N. Commission on Narcotic Drugs. Mr. O’Keeffe played a significant role in helping Congress reach consensus on the Drug Addiction Treatment Act of 2000.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Patrick McEnany

426,512

Alicia Grande

239,800

Steven Miller

318,806

David Muth

--

M. Douglas Winship

258,429

David Caponera

--
As Of 30 Dec 2013
Search Stocks